Published in Z Kardiol on September 01, 1987
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation (1996) 9.00
Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation (1991) 3.70
Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy. Eur Heart J (1999) 2.24
31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation (1998) 2.06
Interactions between pacemakers and security systems. Pacing Clin Electrophysiol (1998) 1.68
Experimental coronary artery occlusion. I. Measurement of infarct size. Basic Res Cardiol (1979) 1.59
The distribution of metastases in the liver. A quantitative postmortem study. Virchows Arch A Pathol Anat Histol (1981) 1.50
Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol (1984) 1.46
Quantitative study on the size of coronary artery supplying areas postmortem. Am Heart J (1977) 1.46
Alcohol and rhythm disturbance: the holiday heart syndrome. Herz (1996) 1.40
[Repeated ingestion with suicidal intent of potentially lethal amounts of thallium]. Dtsch Med Wochenschr (1995) 1.39
[Complicated course of Churg-Strauss syndrome with eosinophilic perimyocarditis and pericardial tamponade]. Dtsch Med Wochenschr (2004) 1.38
Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol (1983) 1.35
Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). Circulation (1997) 1.34
Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. I. Relevance of antibody pattern. Clin Exp Immunol (1979) 1.25
Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford) (2006) 1.24
Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol (1982) 1.23
Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke (1995) 1.18
The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz (2000) 1.14
Reversal of tachycardia induced cardiomyopathy following ablation of repetitive monomorphic right ventricular outflow tract tachycardia. Pacing Clin Electrophysiol (2001) 1.11
Cardiotoxicity of 5-fluorouracil. Cardiovasc Hematol Agents Med Chem (2006) 1.11
QT dispersion and arrhythmic events in idiopathic dilated cardiomyopathy. Am J Cardiol (1996) 1.11
Surgical treatment of 50 carotid dissections: indications and results. J Vasc Surg (2000) 1.07
Complications of third-generation implantable cardioverter defibrillator therapy. Pacing Clin Electrophysiol (1999) 1.06
Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. Am J Cardiol (1996) 1.05
Well-differentiated papillary mesothelioma of the peritoneum: a borderline mesothelioma. Report of two cases and review of literature. Virchows Arch A Pathol Anat Histopathol (1990) 1.05
The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. Eur Heart J (1995) 1.03
Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): response to methotrexate and mercaptopurine. Med Pediatr Oncol (1996) 1.01
Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy. Am J Cardiol (2000) 1.00
The use of local anaesthetic microinjections to identify central pathways: a quantitative evaluation of the time course and extent of the neuronal block. Exp Brain Res (1987) 1.00
Coxsackievirus B3 infection leads to cell death of cardiac myocytes. J Mol Cell Cardiol (1994) 0.99
Giant left atrial mass in an asymptomatic patient. Heart (2004) 0.97
Experimental coronary artery occlusion. II. Spatial and temporal evolution of infarcts in the dog heart. Basic Res Cardiol (1979) 0.97
[Malignant angiosarcoma of the right atrium in pregnancy. Diagnostic and therapeutic problems]. Herz (1994) 0.96
Transthyretin Leu 68 in a form of cardiac amyloidosis. Basic Res Cardiol (1992) 0.96
[Static and dynamic investigations in compression-arthrodesis of the knee-joint (author's transl)]. Z Orthop Ihre Grenzgeb (1973) 0.95
Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope. Eur Heart J (1997) 0.95
Hormonal regulation of cardiac fibroblast function. Eur Heart J (1995) 0.94
[Cardiac rehabilitation--more than just for the garden plot?]. Herz (2012) 0.94
Influence of D-net (European GSM-Standard) cellular phones on pacemaker function in 50 patients with permanent pacemakers. Pacing Clin Electrophysiol (1996) 0.94
Endomyocardial biopsy in infants and children: experience in 60 patients. Pediatr Cardiol (1990) 0.93
Atrial fibrillation and embolic complications in paced patients. Pacing Clin Electrophysiol (1988) 0.93
[Alcohol and myocarditis]. Herz (1996) 0.92
Cardiac amyloid deposits in endomyocardial biopsies. Light microscopic, ultrastructural, and immunohistochemical studies. Am J Clin Pathol (1986) 0.92
Endomyocardial biopsy in infants and children: technique; indications and results. Eur J Pediatr (1982) 0.92
Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover. Am J Cardiol (1995) 0.91
Immunological cellular regulator and effector mechanisms in myocarditis. Herz (1985) 0.91
Apoptosis in myocarditis and dilated cardiomyopathy: does enterovirus genome persistence protect from apoptosis? An endomyocardial biopsy study. Cardiovasc Pathol (2001) 0.91
Regulation of the structural remodelling of the myocardium: from hypertrophy to heart failure. Eur Heart J (1994) 0.90
Cytokine activation in pericardial fluids in different forms of pericarditis. Herz (2000) 0.90
Autoantibodies and serum inhibition factors (sif) in patients with myocarditis. Klin Wochenschr (1980) 0.90
[The etiology, course and prognosis of dilated cardiomyopathy]. Z Kardiol (1982) 0.89
Left ventricular thrombi in three children with dilated cardiomyopathy: diagnostic procedure and clinical course. Pediatr Cardiol (1984) 0.89
Intrapericardial procedures for cardiac regeneration by stem cells: need for minimal invasive access (AttachLifter) to the normal pericardial cavity. Herz (2010) 0.88
Cardiac rhythm and conduction disturbances: what is the role of autoimmune mechanisms? Herz (2000) 0.88
Circadian variation and onset mechanisms of ventricular tachyarrhythmias in patients with coronary disease versus idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol (2000) 0.88
Dilated cardiomyopathy in childhood: problems of diagnosis and long-term follow-up. Eur Heart J (1987) 0.87
Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy. Can J Physiol Pharmacol (2007) 0.87
Managing a complication after direct stenting: removal of a maldeployed stent with rotational atherectomy. Heart (2005) 0.86
Immunological parameters in patients with congestive cardiomyopathy. Basic Res Cardiol (1980) 0.86
Antibodies against stress proteins in sera of patients with dilated cardiomyopathy. J Mol Cell Cardiol (1997) 0.86
Cytomegalovirus-associated heart muscle disease. Eur Heart J (1995) 0.86
Diabetic cardiomyopathy: ongoing controversies in 2012. Herz (2012) 0.86
Transient QT prolongation with torsades de pointes tachycardia after ablation of permanent junctional reciprocating tachycardia. J Cardiovasc Electrophysiol (1999) 0.86
Point mutations in mitochondrial DNA of patients with dilated cardiomyopathy. J Mol Cell Cardiol (1997) 0.86
Identification of mitochondrial antigens recognized by antibodies in sera of patients with idiopathic dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing. Am J Cardiol (1997) 0.86
Immune reactions in tuberculous and chronic constrictive pericarditis. Clinical data and diagnostic significance of antimyocardial antibodies. Am J Cardiol (1982) 0.86
Prevalence of viral genome in endomyocardial biopsies from patients with inflammatory heart muscle disease. Herz (2000) 0.86
Prevention of recurrent ventricular fibrillation by ventricular rate stabilization. Europace (2000) 0.85
Technical considerations for inhaled nitric oxide therapy: time response to nitric oxide dosing changes and formation of nitrogen dioxide. Eur J Pediatr (1997) 0.85
Dysplasia of the systemic and pulmonary arterial system with tortuosity and lengthening of the arteries. A new entity, diagnosed during life, and leading to coronary death in early childhood. Circulation (1969) 0.85
A new methodological approach to assess cardiac work by pressure-volume and stress-length relations in patients with aortic valve stenosis and dilated cardiomyopathy. Pflugers Arch (2007) 0.85
Whole mitochondrial genome amplification reveals basal level multiple deletions in mtDNA of patients with dilated cardiomyopathy. Biochem Biophys Res Commun (1995) 0.85
Clinical and prognostic effect of a positive granulocyte scan in infective endocarditis. Clin Nucl Med (1993) 0.85
Influence of pacing mode and rate on peripheral levels of atrial natriuretic peptide (ANP). Pacing Clin Electrophysiol (1989) 0.84
Heart rate variability and baroreflex sensitivity in idiopathic dilated cardiomyopathy. Heart (2000) 0.84
Ultrastructural findings in endomyocardial biopsy of patients with Kearns-Sayre syndrome. J Am Coll Cardiol (1988) 0.84
[The extracellular matrix and cytoskeleton of the myocardium in cardiac inflammatory reaction]. Herz (1995) 0.84
Gene expression profiles in the acutely dissected human aorta. Eur J Vasc Endovasc Surg (2002) 0.84
Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol (1998) 0.84
Metabolic basis of high density lipoproteins and apolipoprotein A-I increase by HMG-CoA reductase inhibition in healthy subjects and a patient with coronary artery disease. Atherosclerosis (1999) 0.84
Diffuse noxious inhibitory controls of lumbar spinal neurons involve a supraspinal loop in the cat. Brain Res (1987) 0.83
[The so-called isolated hypoplastic right ventricle with atrial septal defect or open foramen ovale]. Med Klin (1965) 0.83
[Light and electron microscopy findings in early and late stages of heart failure. Studies of endomyocardial biopsies of patients with latent (LCM) and dilated (DCM) cardiomyopathy]. Z Kardiol (1985) 0.83
Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy. Basic Res Cardiol (1986) 0.83
Heart rate variability and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. Pacing Clin Electrophysiol (1996) 0.83
Differences in cardiac energetics between patients with familial and nonfamilial hypertrophic cardiomyopathy. Circulation (2000) 0.83
[Capillarization and microscopic changes in the myocardium in congenital heart defects]. Virchows Arch Pathol Anat Physiol Klin Med (1966) 0.83
Treatment of experimental murine Coxsackie B3 myocarditis. Eur Heart J (1991) 0.83
Inhibition of nociceptive responses of lumbar dorsal horn neurones by remote noxious afferent stimulation in the cat. Pain (1988) 0.83
Increased turnover of serotonin in children with pulmonary hypertension secondary to congenital heart disease. Pediatr Cardiol (1997) 0.83
[Value of old and new electrocardiography criteria for differential diagnosis between ventricular tachycardia and supraventricular tachycardia with bundle branch block]. Z Kardiol (1996) 0.83
Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis. Clin Exp Immunol (2000) 0.82
Why does atherosclerosis occur where it occurs? Atherosclerosis (2005) 0.82
Alcohol and the heart. Herz (2001) 0.82
The correlation between blood pressure and morphometric findings in children with congenital heart disease and pulmonary hypertension. Basic Res Cardiol (1982) 0.82